Search results
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
Zacks via Yahoo Finance· 1 year agoRoche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 9 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 5 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 10 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 2 years agoShares of Puma Biotechnology PBYI were up 17.4% at market close on Aug 5, following the earnings...
Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale
Zacks via Yahoo Finance· 7 months agoRoche (RHHBY) reports a sales decline in the first nine months of 2023 as COVID-19-test sales...
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
Zacks via Yahoo Finance· 3 months agoRoche (RHHBY) misses earnings and sales estimates in 2023 due to a significant decline in...
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Zacks via Yahoo Finance· 3 weeks agoRoche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue...